Reliability Study of a Motor Function Measure Digitalized Playful Completion Modules
MFM-Play
1 other identifier
observational
70
1 country
10
Brief Summary
Neuromuscular diseases include more than 200 rare disorders affecting muscles or the nervous system. Functional scales assessing motor function are tools allowing to measure the evolution of motor impairment of patients with a neuromuscular disease. They are frequently used as main outcome measures in clinical trials which are currently in full development thanks to advances in genetic and drug researches. Among the available scales, the Motor Function Measure (MFM), a scale consisting of 32 items, had shown good metrological properties in terms of validity, reliability and sensitivity to change, regardless of the diagnosis and extent of motor impairment. By exploring the potential of digital technologies applied to MFM, investigators created a completion module composed of animations with different playful and informative scenarios displayed on a digital tablet. The main purpose of this project is to conduct a multicentre study to assess reliabilities of the MFM completed using the MFM-Play. Expected benefits of this project are to improve the experience and the participation of the children to who is often imposed multiple assessments during the numerous follow-up visits of clinical trials, while maintaining good metrological properties of the MFM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2022
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedStudy Start
First participant enrolled
November 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 3, 2024
CompletedNovember 4, 2024
October 1, 2024
1.6 years
January 26, 2022
October 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of item scoring between 2 MFM completion.
Level of agreement between MFM item scores reported by physiotherapists during 2 different MFM completion using the MFM-Play. Level of agreement between MFM item scores reported by a same physiotherapist during a MFM completion using the MFM-Play and a MFM completed conventionally.
3 months
Study Arms (1)
MFM-Play
Neuromuscular disease patients completed MFM using MFM-Play
Interventions
Patients will completed 3 MFM during the follow-up, two times using the MFM-Play, and one without the MFM-Play Delay between each MFM completion will be 1 month ± 15 days
Eligibility Criteria
Patients with a follow-up in a French neuromuscular reference center
You may qualify if:
- Patients with a neuromuscular disease confirmed by the clinic, electroneuromyography (ENMG), biology, muscular biopsy, or genetic
- aged ≥ 2 yo and ≤ 60 yo
- having been informed and not objecting to participating in the study (information and non-opposition of parents/holders of parental authority for minor patients)
You may not qualify if:
- having had surgery or illness impacting their motor function within the last 6 months
- having understanding and/or behavioral deficiencies preventing rigorous assessment
- Patient placed under legal protection (this includes guardianship, curatorship and safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Centre de référence maladies neuromusculaires Hôpital Morvan - CHRU de Brest
Brest, 29200, France
Service de Rééducation Fonctionnelle Pédiatrique - L'Escale - Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Bron, 69500, France
Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital Couple-Enfant CHU de Grenoble
La Tronche, 38700, France
Centre de référence maladies neuromusculaires Hôpital Salengro CHU Lille
Lille, 59000, France
Consultation pluridisciplinaire MNM adulte Hôpital de la Croix Rousse, Groupement Hospitalier Nord HCL
Lyon, 69004, France
ESEAN - APF France Handicap
Nantes, 44200, France
Consultation de pédiatrie- maladie neuromusculaire Hôpital Armand Trousseau APHP
Paris, 75012, France
Service de Médecine Physique et de Réadaptation Pédiatrique Hôpital Bellevue CHU Saint Etienne
Saint-Etienne, 42000, France
Centre de référence MNM Adulte Saint Etienne - service neurologie CHU Hôpital Nord
Saint-Priest-en-Jarez, 42270, France
Centre de référence des maladies neuromusculaires enfants Hôpital des enfants CHU de Toulouse
Toulouse, 31059, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2022
First Posted
February 7, 2022
Study Start
November 17, 2022
Primary Completion
July 3, 2024
Study Completion
July 3, 2024
Last Updated
November 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share